Sensitivity of HIV-1 to neutralization by antibodies against O-linked carbohydrate epitopes despite deletion of O-glycosylation signals in the V3 loop
- 1 February 1996
- journal article
- research article
- Published by Springer Nature in Archiv für die gesamte Virusforschung
- Vol. 141 (2) , 291-300
- https://doi.org/10.1007/bf01718400
Abstract
Summary It has been suggested that threonine or serine residues in the V3 loop of HIV-1 gp120 are glycosylated with the short-chain O-linked oligosaccharides Tn or sialosyl-Tn that function as epitopes for broadly neutralizing carbohydrate specific antibodies. In this study we examined whether mutation of such threonine or serine residues could decrease the sensitivity to infectivity inhibition by Tn or sialosyl-Tn specific antibodies. All potentially O-glycosylated threonine and serine residues in the V3 loop of cloned HIV-1BRU were mutagenized to alanine thus abrogating any O-glycosylation at these sites. Additionally, one of these T-A mutants (T308A) also abrogated the signal for N-glycosylation at N306 inside the V3-loop. The mutant clones were compared with the wild type virus as to sensitivity to neutralization with monoclonal and polyclonal antibodies specific for the tip of the V3 loop of BRU or for the O-linked oligosaccharides Tn or sialosyl-Tn. Deletion of the N-linked oligosaccharide at N306 increased the neutralization sensitivity to antibodies specific for the tip of the loop, which indicates that N-linked glycosylation modulates the accessibility to this immunodominant epitope. However, none of the mutants with deletions of O-glycosylation signals in the V3 loop displayed any decrease in sensitivity to anti-Tn or anti-sialosyl-Tn antibody. This indicates that these broadly specific neutralization epitopes are located outside the V3 loop of gp120.Keywords
This publication has 21 references indexed in Scilit:
- An N-Glycan within the Human Immunodeficiency Virus Type 1 gp120 V3 Loop Affects Virus NeutralizationVirology, 1994
- An O-linked carbohydrate neutralization epitope of HIV-1 gp 120 is expressed by HIV-1env gene recombinant vaccinia virusArchiv für die gesamte Virusforschung, 1992
- Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp 120AIDS, 1990
- Conserved Sequence and Structural Elements in the HIV-1 Principal Neutralizing DeterminantScience, 1990
- An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1AIDS, 1989
- Sensitive ELISA for the gp120 and gp160 Surface Glycoproteins of HIV-1AIDS Research and Human Retroviruses, 1988
- Identification of Sequences in Epstein-Barr Virus DNA Required for the Expression of the Second Epstein-Barr Virus-determined Nuclear Antigen in COS-1 CellsJournal of General Virology, 1987
- Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque AssayScience, 1985
- Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDSScience, 1984
- Enchancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran.1968